Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 1, 2013, Pages 25-32

  McEwen, Bradley J ^a,b   Morel Kopp, Marie Christine ^a,b   Chen, Walter ^a,b   Tofler, Geoffrey H ^b   Ward, Christopher M ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

cardiovascular disease; omega 3 PUFA; platelet activation; platelet aggregation; thrombosis

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PADGEM PROTEIN;

ADULT; ANALYSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE AGGREGATION; LIGHT TRANSMISSION AGGREGOMETRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EICOSAPENTAENOIC ACID; EPINEPHRINE; FATTY ACIDS, OMEGA-3; HUMANS; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION; YOUNG ADULT;

EID: 84873406088     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1333309     Document Type: Article

References (40)

1. Roger V. L., Go A. S., Lloyd-Jones D. M., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation: 2012; 125 1 e2 e220
2. Begonja A. J., Gambaryan S., Geiger J., et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway. Blood: 2005; 106 8 2757 2760
3. McNicol A., Israels S. J. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res: 1999; 95 1 1 18
4. Davì G., Patrono C. Platelet activation and atherothrombosis. N Engl J Med: 2007; 357 24 2482 2494
5. Ruggeri Z. M. Platelets in atherothrombosis. Nat Med: 2002; 8 11 1227 1234
6. Blann A. D., Lip G. Y. Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res: 2001; 101 4 321 327
7. Hechler B., Cattaneo M., Gachet C. The P2 receptors in platelet function. Semin Thromb Hemost: 2005; 31 2 150 161
8. Schulz C., Penz S., Hoffmann C., et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol: 2008; 103 4 356 367
9. Munnix I. C., Cosemans J. M., Auger J. M., Heemskerk J. W. Platelet response heterogeneity in thrombus formation. Thromb Haemost: 2009; 102 6 1149 1156
10. Shantsila E., Lip G. Y. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost: 2009; 102 5 916 924
11. Freedman J. E., Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation: 2002; 105 18 2130 2132
12. Lippi G., Montagnana M., Salvagno G. L., et al. Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol: 2007; 115 1 101 102
13. Sarma J., Laan C. A., Alam S., Jha A., Fox K. A., Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation: 2002; 105 18 2166 2171
14. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost: 2009; 35 2 158 167
15. Born G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature: 1962; 194 927 929
16. Michelson A. D., Barnard M. R., Krueger L. A., Frelinger A. L. III, Furman M. I. Evaluation of platelet function by flow cytometry. Methods: 2000; 21 3 259 270
17. Michelson A. D. Flow cytometry: a clinical test of platelet function. Blood: 1996; 87 12 4925 4936
18. Favaloro E. J. Clinical utility of the PFA-100. Semin Thromb Hemost: 2008; 34 8 709 733
19. Harrison P., Robinson M., Liesner R., et al. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol: 2002; 24 4 225 232
20. Benatti P., Peluso G., Nicolai R., Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr: 2004; 23 4 281 302
21. Kris-Etherton P. M., Harris W. S., Appel L. J. Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol: 2003; 23 2 e20 e30
22. Marchioli R., Barzi F., Bomba E., et al. GISSI-Prevenzione Investigators Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation: 2002; 105 16 1897 1903
23. Tavazzi L., Maggioni A. P., Marchioli R., et al. Gissi-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet: 2008; 372 9645 1223 1230
24. Singer P., Wirth M. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial. Prostaglandins Leukot Essent Fatty Acids: 2004; 71 3 153 159
25. Bays H. E., Tighe A. P., Sadovsky R., Davidson M. H. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther: 2008; 6 3 391 409
26. Calder P. C. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res: 2012; 56 7 1073 1080
27. Mori T. A., Watts G. F., Burke V., Hilme E., Puddey I. B., Beilin L. J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation: 2000; 102 11 1264 1269
28. Din J. N., Newby D. E., Flapan A. D. Omega 3 fatty acids and cardiovascular disease-fishing for a natural treatment. BMJ: 2004; 328 7430 30 35
29. Harris W. S., Kris-Etherton P. M., Harris K. A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep: 2008; 10 6 503 509
30. Surette M. E. The science behind dietary omega-3 fatty acids. CMAJ: 2008; 178 2 177 180
31. Gebauer S. K., Psota T. L., Harris W. S., Kris-Etherton P. M. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr: 2006; 83 6 (Suppl): 1526S 1535S
32. National Heart Foundation of Australia Position Statement: Fish, Fish Oils, n-3 Polyunsaturated Fatty Acids and Cardiovascular Health. Canberra, Australian Capital Territory, Australia National Heart Foundation of Australia: 2008
33. Mackay I., Ford I., Thies F., Fielding S., Bachoo P., Brittenden J. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease. Atherosclerosis: 2012; 221 2 514 520
34. Serebruany V. L., Miller M., Pokov A. N., et al. Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. Cardiology: 2011; 118 3 187 194
35. Cohen M. G., Rossi J. S., Garbarino J., et al. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res: 2011; 128 4 335 340
36. Doenyas-Barak K., Berman S., Abu-Hamad R., Golik A., Rahimi-Levene N., Efrati S. N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status. Eur J Clin Pharmacol: 2012; 68 8 1139 1146
37. Undas A., Brummel-Ziedins K. E., Mann K. G. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood: 2007; 109 6 2285 2292
38. Din J. N., Harding S. A., Valerio C. J., et al. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis: 2008; 197 1 290 296
39. Nomura S., Kanazawa S., Fukuhara S. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus. J Diabetes Complications: 2003; 17 3 153 159
40. Marwali M. R., Hu C. P., Mohandas B., et al. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther: 2007; 322 3 1324 1332